• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is Political.诊断临床前和前驱神经退行性疾病——临床即政治。
JAMA Neurol. 2024 May 1;81(5):439-440. doi: 10.1001/jamaneurol.2023.5684.
2
[Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases].未雨绸缪——神经退行性疾病的寡症状前驱期
Nervenarzt. 2024 Aug;95(8):689-696. doi: 10.1007/s00115-024-01654-0. Epub 2024 Apr 17.
3
Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases.检测前驱神经退行性疾病的非认知特征。
Curr Aging Sci. 2019;11(4):242-249. doi: 10.2174/1874609812666190204094233.
4
[Foreword].
Rev Neurol (Paris). 2012 Nov;168(11):795. doi: 10.1016/j.neurol.2012.10.006.
5
Depression as a Prodromal Symptom of Neurodegenerative Diseases.抑郁作为神经退行性疾病的前驱症状。
J Nippon Med Sch. 2023;90(2):157-164. doi: 10.1272/jnms.JNMS.2023_90-216.
6
The theoretical problems of "prodrome" and "phenoconversion" in neurodegeneration.神经退行性变中“前驱症状”和“表型转换”的理论问题。
Handb Clin Neurol. 2023;192:155-167. doi: 10.1016/B978-0-323-85538-9.00002-X.
7
[A restless REM sleep may be sign of emerging neurodegenerative diseases].
Med Sci (Paris). 2018 Oct;34(10):771-773. doi: 10.1051/medsci/2018200. Epub 2018 Nov 19.
8
Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?特发性 REM 睡眠行为障碍患者的长期无病生存：神经退行性变是否不可避免？
Parkinsonism Relat Disord. 2018 Sep;54:99-102. doi: 10.1016/j.parkreldis.2018.04.010. Epub 2018 Apr 4.
9
Prodromal spinocerebellar ataxia type 2: Prospects for early interventions and ethical challenges.2型前驱性脊髓小脑共济失调：早期干预的前景与伦理挑战
Mov Disord. 2017 May;32(5):708-718. doi: 10.1002/mds.26969. Epub 2017 Mar 3.
10
Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset.路易体痴呆前驱期：症状演变及痴呆发病预测因素。
J Geriatr Psychiatry Neurol. 2022 Jul;35(4):527-534. doi: 10.1177/08919887211023586. Epub 2021 Jun 11.

引用本文的文献

1
Ethics of disclosure of onset-predictive biomarker test results for genetic frontotemporal dementia in the research context.研究背景下遗传性额颞叶痴呆发病预测生物标志物检测结果披露的伦理问题。
Alzheimers Dement (Amst). 2025 Jun 11;17(2):e70133. doi: 10.1002/dad2.70133. eCollection 2025 Apr-Jun.
2
The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathies.前驱期个体对α-突触核蛋白病早期检测主动招募的看法。
NPJ Parkinsons Dis. 2025 May 9;11(1):121. doi: 10.1038/s41531-025-00979-0.
3
Biomarker-Driven Diagnosis in Neurocognitive Disorders: A Clinician's Perspective on the Risks of Reductionism.神经认知障碍中基于生物标志物的诊断：临床医生对还原论风险的看法
Neurol Clin Pract. 2025 Jun;15(3):e200481. doi: 10.1212/CPJ.0000000000200481. Epub 2025 May 2.
4
Paving the way for Alzheimer's disease blood-based biomarkers in primary care.为初级保健中基于血液的阿尔茨海默病生物标志物铺平道路。
Alzheimers Dement. 2025 Jan;21(1):e14203. doi: 10.1002/alz.14203. Epub 2024 Dec 30.
5
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.肌萎缩侧索硬化症/额颞叶痴呆遗传风险升高的致病基因变异携带者临床管理指南
J Neurol Neurosurg Psychiatry. 2025 Jan 31;96(3). doi: 10.1136/jnnp-2024-334339.
6
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson's Disease: A Narrative Review.识别帕金森病前驱期/早期个体的伦理考虑：叙事综述。
J Parkinsons Dis. 2024;14(s2):S307-S319. doi: 10.3233/JPD-230428.
7
The Ethical Landscape of Prodromal Parkinson Disease: Considerations for Shared Decision-Making and Health Equity.前驱期帕金森病的伦理格局：共同决策与健康公平的考量
Neurology. 2024 Jun 11;102(11):e209522. doi: 10.1212/WNL.0000000000209522. Epub 2024 May 17.

本文引用的文献

1
Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum.阿尔茨海默病生物标志物检测及在疾病连续体中的结果披露
Neurology. 2023 May 23;100(21):1010-1019. doi: 10.1212/WNL.0000000000206891. Epub 2023 Jan 31.
2
Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society.临床前阿尔茨海默病生物标志物披露对美国政策和社会的影响。
Alzheimers Dement (Amst). 2022 Aug 25;14(1):e12339. doi: 10.1002/dad2.12339. eCollection 2022.
3
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.超越披露：临床前阿尔茨海默病生物标志物检测中的护理阶段。
Alzheimers Dement. 2022 Oct;18(10):1969-1979. doi: 10.1002/alz.12620. Epub 2022 Feb 25.
4
The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment.生物标志物、疾病修正治疗和痴呆严重程度对阿尔茨海默病污名的相对贡献：基于情景的实验。
Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.
5
Preclinical Alzheimer Disease and the Dawn of the Pre-Caregiver.临床前阿尔茨海默病与预照料者时代的曙光。
JAMA Neurol. 2019 Jun 1;76(6):631-632. doi: 10.1001/jamaneurol.2019.0165.
6
Patients-in-waiting: Living between sickness and health in the genomics era.候诊患者：在基因组学时代，游走于疾病与健康之间。
J Health Soc Behav. 2010 Dec;51(4):408-23. doi: 10.1177/0022146510386794.

Diagnosing Preclinical and Prodromal Neurodegenerative Diseases-The Clinical Is Political.

作者信息

Erickson Claire M, Largent Emily A

机构信息

Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia.

出版信息

JAMA Neurol. 2024 May 1;81(5):439-440. doi: 10.1001/jamaneurol.2023.5684.

DOI:10.1001/jamaneurol.2023.5684
PMID:38372983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11090734/
Abstract
摘要